{
    "2021-12-20": [
        [
            {
                "time": "",
                "original_text": "公告精选：中装建设与鸿蒙时代等拟联合开发元宇宙应用等项目；三峡能源拟合计411.69亿元投建三个海上风电场项目",
                "features": {
                    "keywords": [
                        "中装建设",
                        "鸿蒙时代",
                        "元宇宙",
                        "三峡能源",
                        "海上风电"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "并购再出牛股！7成个股股价飘红，15股已翻番",
                "features": {
                    "keywords": [
                        "并购",
                        "牛股",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：SPH4336片获得美国FDA药品II期临床试验批准",
                "features": {
                    "keywords": [
                        "上海医药",
                        "SPH4336",
                        "FDA",
                        "临床试验"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "增资1.5个亿，上海医药战略投资越洋医药",
                "features": {
                    "keywords": [
                        "上海医药",
                        "增资",
                        "越洋医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}